BRIEF-Vyne Therapeutics Completes Enrollment In Phase 2B Trial Evaluating VYN201

Reuters
06 Jan
BRIEF-Vyne <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Completes Enrollment In Phase 2B Trial Evaluating VYN201

Jan 6 (Reuters) - Vyne Therapeutics Inc VYNE.O:

  • VYNE THERAPEUTICS COMPLETES ENROLLMENT IN PHASE 2B TRIAL EVALUATING VYN201 FOR THE TREATMENT OF NONSEGMENTAL VITILIGO

  • VYNE THERAPEUTICS INC - TOP-LINE DATA FROM VYN201 TRIAL EXPECTED IN MID-2025

Source text: nGNX41cC3v

Further company coverage: VYNE.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10